Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.
- NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_assertion description "[In neonates, CpG pretreatment led to a transient increase in expression of major histocompatibility complex class II (MHCII) and CD80 on CD11c-positive cells and gamma interferon (IFN-?) production by NK cells after RSV infection, suggesting that the protective effects may be mediated by antigen-presenting cells (APC) and NK cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.
- NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_assertion evidence source_evidence_literature NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.
- NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_assertion SIO_000772 22811525 NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.
- NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_assertion wasDerivedFrom befree-20150227 NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.
- NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_assertion wasGeneratedBy ECO_0000203 NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP291863.RAVZQfIRGc-zR28IQVuWrl11g7jaMgRtsdIOtcA_Ci2gM130_provenance.